These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 13276475

  • 1. [Rational approach to therapy of cancer with haloalkylamines and with ethylenemelanines].
    ZHDANOV GL.
    Biull Eksp Biol Med; 1955 Sep; 40(9):65-9. PubMed ID: 13276475
    [No Abstract] [Full Text] [Related]

  • 2. Clinical indications for the use of nitrogen mustard and triethylene melamine in malignant lymphomas and leukemias.
    DIAMOND HD.
    Ann N Y Acad Sci; 1958 Apr 24; 68(3):974-8. PubMed ID: 13627744
    [No Abstract] [Full Text] [Related]

  • 3. Changes in the urinary excretion of metabolites during treatment with nitrogen mustard and triethylenemelamine.
    GERBRANDY J, HELLENDOORN HB.
    Br J Cancer; 1958 Sep 24; 12(3):458-68. PubMed ID: 13596499
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Palliative therapy of incurable intrathoracic malignancies.
    SKINNER EF, CARR D.
    Am Pract Dig Treat; 1952 Nov 24; 3(11):900-10. PubMed ID: 12996795
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. HODGKIN'S disease: diagnosis and treatment.
    Med J Aust; 1953 Jun 27; 1(26):934-5. PubMed ID: 13070940
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Diagnosis and therapy of Hodgkin's disease; study of 110 cases].
    JUSTIN-BESANCON L, LAMOTTE-BARRILLON S, DEBRAY J.
    Sem Hop; 1952 Dec 25; 28(95):3855-71. PubMed ID: 13048712
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of Hodgkin's disease and the lymphosarcomas.
    MEYER OO.
    J Am Med Assoc; 1954 Jan 09; 154(2):114-20. PubMed ID: 13108678
    [No Abstract] [Full Text] [Related]

  • 12. Comparative effects of total body radiation, nitrogen mustard, and triethylene melamine on the hematopoietic system of terminal cancer patients.
    LOEFFLER RK, COLLINS VP, HYMAN GA.
    Science; 1953 Aug 07; 118(3058):161-3. PubMed ID: 13076229
    [No Abstract] [Full Text] [Related]

  • 13. The oral use of triethylene melamine; a compound with nitrogen mustard-like activity.
    KARNOFSKY DA, BURCHENAL JH, BERNSTEIN JL, SOUTHAM CM.
    Acta Unio Int Contra Cancrum; 1953 Aug 07; 9(1):97-100. PubMed ID: 13057680
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Studies on the N-dealkylation of nitrogen mustard and triethylenemelamine by liver homogenates.
    NADKARNI MV, TRAMS EG.
    Cancer Res; 1956 Dec 07; 16(11):1069-75. PubMed ID: 13383476
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [New research on the protective effect exercised by diverse sulfhydryl compounds in comparison with toxicity of nitrogen mustards and triethylene melamine].
    DEYSSON G, TRUHAUT R.
    C R Seances Soc Biol Fil; 1956 Nov 18; 150(6):1171-3. PubMed ID: 13383924
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Triethylene melamine treatment of leukemia and lymphogranulomatosis].
    CAKMAKCI A.
    Turk Tip Cemiy Mecm; 1954 Jun 18; 20(6):290-314. PubMed ID: 13217043
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.